Bio Port Korea Inc. (KOSDAQ:188040)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,100.00
-60.00 (-1.16%)
At close: Sep 1, 2026

Bio Port Korea Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
77,97570,88073,34668,699
Revenue Growth
7.37%-3.36%6.77%-
Gross Profit
19,43317,32020,93619,083
Operating Income
2,394830.055,2404,919
Net Income
2,963-1,4034,1123,369
Earnings Per Share
654.00-336.141438.991302.58
EPS Growth
253.96%-10.47%-

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
South Korea
42,00837,35642,815
Overseas
28,87235,99025,884
Total
70,88073,34668,699

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
20,46819,16011,7637,546
Total Debt
16,85211,81014,42924,306
Net Cash (Debt)
3,6167,350-2,666-16,760
Net Cash Growth
-67.51%---
Net Cash Per Share
798.321760.47-744.93-4732.22

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-1,7734,74112,0742,022
Capital Expenditures
-4,706-2,254-3,584-3,275
Free Cash Flow
-6,4792,4868,491-1,253
Free Cash Flow Growth
--70.72%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
24.92%24.44%28.54%27.78%
Operating Margin
3.07%1.17%7.14%7.16%
Pretax Margin
3.53%-2.61%7.30%5.23%
Profit Margin
3.80%-1.98%5.61%4.91%
FCF Margin
-8.31%3.51%11.58%-1.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PE Ratio
7.80-2.943.35
Forward PE
-4.57--
P/FCF Ratio
-14.931.42-
PS Ratio
0.300.520.170.16